Results 231 to 240 of about 107,703 (261)

How the sales of oral nicotine pouches correlate with prices and respond to taxes on cigarettes and e‐cigarettes

Addiction, EarlyView.
Abstract Background and aims Oral nicotine pouches (ONPs) have seen a dramatic rise in sales since their introduction to the US market in 2016. We aimed to define the relationship between ONP prices and sales (e.g. price elasticity of demand) and determine how taxes on cigarettes and e‐cigarettes (ECs) impact ONP sales.
Yanyun He, Zezhong Zhang, Brittney Keller‐Hamilton, Megan E. Roberts, Darren Mays, Theodore L. Wagener, Micah L. Berman, Ce Shang   +7 more
wiley   +1 more source

Pyrroloquinoline Quinone and NAD⁺ Metabolism in Glaucoma: A Molecular Rationale for Combined Neuroprotection. [PDF]

Pharmaceuticals (Basel)
Medoro A, Davinelli S, Mazzotta CG, Agnifili L, Scapagnini G.   +4 more
europepmc   +1 more source

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source

Escalating rocuronium dosing in the era of sugammadex for neuromuscular blockade reversal. [PDF]

J Thorac Dis
Farag E, Wang L, Sleiman VB, Argalious M.   +3 more
europepmc   +1 more source

Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era

Addiction, EarlyView.
Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley   +1 more source

An Open-Label Trial of Effects of Varenicline in Nonconstipation Irritable Bowel Syndrome and Pain. [PDF]

Clin Gastroenterol Hepatol
Matar A, Busciglio I, Eckert D, Linden DR, Harmsen WS, Camilleri M.   +5 more
europepmc   +1 more source

Metabolic Engineering of <i>Pseudomonas putida</i> KT2440 for β-Nicotinamide Mononucleotide Biosynthesis from Glucose and Aspartate. [PDF]

Microorganisms
Gao L, Wei L, Wang S, Li J, Liu J, Guo Z, Li ZM, Li Z.   +7 more
europepmc   +1 more source

Discriminative stimulus and locomotor activity profiles of nicotine and varenicline. [PDF]

Pharmacol Biochem Behav
Kusi-Boadum NK, Taylor CM, Shetty RA, Sumien N, Forster MJ.   +4 more
europepmc   +1 more source

Is FH a curable disease? [PDF]

Glob Cardiol Sci Pract
Seidah NG.
europepmc   +1 more source

Advances in research on pharmacological mechanisms of anatabine: from nicotinic modulation to multitarget therapeutic potential. [PDF]

Exp Biol Med (Maywood)
Li X, Liu X, Sheng H, Guo J, Zhang L, Fei T, Gao Y.   +6 more
europepmc   +1 more source